HMOX1 and inflammatory bowel disease: Although both smoking and nicotine administration lower the exaggerated IL-1β response in IBD patients [61,62], the present study does not indicate that smoking at the time of diagnosis influences IBD risk by pathways involving IL-1β, IL-10 or HO-1, since the polymorphisms had no effect among present smokers.